Your browser doesn't support javascript.
loading
Time to Recover From Daily Caffeine Intake.
Lin, Yu-Shiuan; Weibel, Janine; Landolt, Hans-Peter; Santini, Francesco; Garbazza, Corrado; Kistler, Joshua; Rehm, Sophia; Rentsch, Katharina; Borgwardt, Stefan; Cajochen, Christian; Reichert, Carolin F.
  • Lin YS; Centre for Chronobiology, University Psychiatric Clinics Basel, Basel, Switzerland.
  • Weibel J; Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Basel, Switzerland.
  • Landolt HP; Neuropsychiatry and Brain Imaging, University Psychiatric Clinics Basel, Basel, Switzerland.
  • Santini F; Centre for Chronobiology, University Psychiatric Clinics Basel, Basel, Switzerland.
  • Garbazza C; Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Basel, Switzerland.
  • Kistler J; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
  • Rehm S; Sleep and Health Zurich, University Center of Competence, University of Zurich, Zurich, Switzerland.
  • Rentsch K; Division of Radiological Physics, Department of Radiology, University Hospital Basel, Basel, Switzerland.
  • Borgwardt S; Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
  • Cajochen C; Centre for Chronobiology, University Psychiatric Clinics Basel, Basel, Switzerland.
  • Reichert CF; Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Basel, Switzerland.
Front Nutr ; 8: 787225, 2021.
Article en En | MEDLINE | ID: mdl-35187019
ABSTRACT
Caffeine elicits widespread effects in the central nervous system and is the most frequently consumed psychostimulant worldwide. First evidence indicates that, during daily intake, the elimination of caffeine may slow down, and the primary metabolite, paraxanthine, may accumulate. The neural impact of such adaptions is virtually unexplored. In this report, we leveraged the data of a laboratory study with N = 20 participants and three within-subject conditions caffeine (150 mg caffeine × 3/day × 10 days), placebo (150 mg mannitol × 3/day × 10 days), and acute caffeine deprivation (caffeine × 9 days, afterward placebo × 1 day). On day 10, we determined the course of salivary caffeine and paraxanthine using liquid chromatography-mass spectrometry coupled with tandem mass spectrometry. We assessed gray matter (GM) intensity and cerebral blood flow (CBF) after acute caffeine deprivation as compared to changes in the caffeine condition from our previous report. The results indicated that levels of paraxanthine and caffeine remained high and were carried overnight during daily intake, and that the levels of paraxanthine remained elevated after 24 h of caffeine deprivation compared to placebo. After 36 h of caffeine deprivation, the previously reported caffeine-induced GM reduction was partially mitigated, while CBF was elevated compared to placebo. Our findings unveil that conventional daily caffeine intake does not provide sufficient time to clear up psychoactive compounds and restore cerebral responses, even after 36 h of abstinence. They also suggest investigating the consequences of a paraxanthine accumulation during daily caffeine intake.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2021 Tipo del documento: Article